Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome in treatment-naïve transgender people assigned female at birth.

Endocrine - 1 Apr 2024

Oğuz Seda Hanife, Boyraz Beyza Seda, Ertürk Banu, Yıldız Bülent Okan

Abstract excerpt

PURPOSE: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among women of reproductive age. We aimed to investigate the prevalence and phenotypic characteristics of PCOS in testosterone treatment-naïve transgender people assigned female at birth (AFAB), as well as to determine whether cardiometabolic risk factors vary based on the presence of PCOS and its components. METHODS: Evaluation of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Androgens
Share to Cardiovascular Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hyperandrogenism

Share to Polycystic Ovary Syndrome

Share to Prevalence

Share to Testosterone

Share to Young Adult

Source

Identifiers

PMID: 38141060
DOI: 10.1007/s12020-023-03648-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome in treatment-naïve transgender people assigned female at birth.PMID 38141060Read ↗

Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.Semantic proximity Read ↗

Prevalence, Phenotypes, and Comorbidities of Polycystic Ovary Syndrome Among Indian Women.Semantic proximity Read ↗

Polycystic ovary syndrome: Criteria, phenotypes, race and ethnicitySemantic proximity Read ↗

Clinical and laboratory features in women with different phenotypes of polycystic ovary syndrome.Semantic proximity Read ↗

Metabolic risk assessment of Indian women with polycystic ovarian syndrome in relation to four Rotterdam criteria based phenotypes.Semantic proximity Read ↗

Consensus on women's health aspects of polycystic ovary syndrome (PCOS).Semantic proximity Read ↗

Approach to the Patient: Diagnostic Challenges in the Workup for Polycystic Ovary SyndromeSemantic proximity Read ↗

Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria.Semantic proximity Read ↗

[Polycystic ovary syndrome: is there a rise in the prevalence?].Semantic proximity Read ↗

Polycystic ovary syndrome--phenotypes and diagnosis.Semantic proximity Read ↗

Metabolic syndrome and metabolic risk profile according to polycystic ovary syndrome phenotype.Semantic proximity Read ↗

Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.